4
Changes in Ownership
GYRE THERAPEUTICS, INC. Filed Acc 0001140361-12-026754
SVP, Preclinical Research acquired 15,938 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Bencherif Merouane · SVP, Preclinical Research
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2012-05-18 | Exercise or conversion : show line 1 in the form | +15,938 | $2.93 | $46,698 | 15,938 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2012-05-18 | Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) | −15,938 | $2.93 | 2019-01-08 | 15,938 | 7,970 | D |
Loading xslF345X03/doc1.xml…